DOW-COLORCON Alliance will commercialize next-generation HPMC excipient by year-end to help lower tablet manufacturing costs by up to 60 percent
Publication date: 9 October 2014
Author(s): The Controlled Release Alliance of Dow Pharma & Food Solutions